Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.00 – $12.10
83% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244.7M | $246.9M | $248.0M | $259.1M | $263.2M | $258.4M | $257.6M | −$77.4M |
| Cost of revenue | $0 | $0 | $0 | $157.0M | $166.0M | $192.6M | $179.2M | $176.1M |
| Gross profit | $244.7M | $246.9M | $248.0M | $102.1M | $97.2M | $65.7M | $78.4M | −$253.4M |
| Gross margin | 100.0% | 100.0% | 100.0% | 39.4% | 36.9% | 25.4% | 30.4% | 327.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.8M | $3.2M | $218.1M | −$3.1M | −$5.8M | $2.3M | $11.1M | −$715.9K |
| EBITDA | $3.8M | $3.2M | $2.9M | −$3.1M | −$5.8M | $2.3M | $11.1M | −$715.9K |
| Net income | $1.6M | $1.4M | $1.8M | −$5.3M | −$5.6M | $1.9M | $6.5M | −$1.4M |
| Net margin | 0.7% | 0.6% | 0.7% | -2.0% | -2.1% | 0.7% | 2.5% | 1.8% |
| EPS (diluted) | 0.09 | 0.08 | 0.07 | -0.31 | -0.33 | 0.11 | 0.38 | -0.08 |
Annual figures · source: Financial Modeling Prep
PEKIN LIFE INS CO CAP
No one on the platform currently holds PKIN.
No tracked institution reports a position in PKIN as of their last filing.
No one on the platform has traded PKIN yet.
| +0.00% |
| $287M |
| — |
| FNRNFirst Northern Community Bancorp | $17.67 | -0.28% | $290M | — |
| HONTHonat Bancorp, Inc. | $139.66 | +0.47% | $200M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.8× sales vs its 0.8× historical median P/S.
Fair value ≈ $11.55 · price $11.75 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.